Cerus Net Income 2010-2023 | CERS
Cerus net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Cerus Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-37 |
| 2022 | $-43 |
| 2021 | $-54 |
| 2020 | $-60 |
| 2019 | $-71 |
| 2018 | $-58 |
| 2017 | $-61 |
| 2016 | $-63 |
| 2015 | $-56 |
| 2014 | $-39 |
| 2013 | $-43 |
| 2012 | $-16 |
| 2011 | $-17 |
| 2010 | $-17 |
| 2009 | $-24 |
| Cerus Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-1 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-13 |
| 2023-03-31 | $-16 |
| 2022-12-31 | $-14 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $-8 |
| 2022-03-31 | $-12 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $-12 |
| 2021-06-30 | $-15 |
| 2021-03-31 | $-17 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-14 |
| 2020-06-30 | $-15 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-17 |
| 2019-09-30 | $-18 |
| 2019-06-30 | $-18 |
| 2019-03-31 | $-19 |
| 2018-12-31 | $-16 |
| 2018-09-30 | $-14 |
| 2018-06-30 | $-13 |
| 2018-03-31 | $-14 |
| 2017-12-31 | $-11 |
| 2017-09-30 | $-13 |
| 2017-06-30 | $-17 |
| 2017-03-31 | $-19 |
| 2016-12-31 | $-14 |
| 2016-09-30 | $-14 |
| 2016-06-30 | $-18 |
| 2016-03-31 | $-17 |
| 2015-12-31 | $-15 |
| 2015-09-30 | $-16 |
| 2015-06-30 | $-16 |
| 2015-03-31 | $-9 |
| 2014-12-31 | $-20 |
| 2014-09-30 | $-11 |
| 2014-06-30 | $-8 |
| 2014-03-31 | $-0 |
| 2013-12-31 | $-6 |
| 2013-09-30 | $-21 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-10 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-2 |
| 2012-03-31 | $-9 |
| 2011-12-31 | $-8 |
| 2011-09-30 | $2 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-5 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $-4 |
| 2010-06-30 | $-6 |
| 2010-03-31 | $-5 |
| 2009-12-31 | $-5 |
| 2009-09-30 | $-6 |
| 2009-06-30 | $-6 |
| 2009-03-31 | $-7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.370B | $0.156B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.261B | 23.87 |
| Stryker (SYK) | United States | $123.641B | 29.61 |
| Medtronic (MDT) | Ireland | $110.900B | 15.70 |
| Boston Scientific (BSX) | United States | $106.819B | 34.02 |
| EssilorLuxottica (ESLOY) | France | $100.527B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.760B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.671B | 27.50 |
| ResMed (RMD) | United States | $32.010B | 30.05 |
| Terumo (TRUMY) | Japan | $25.312B | 35.75 |
| Koninklijke Philips (PHG) | Netherlands | $25.036B | 19.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.603B | 15.72 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $11.278B | 50.01 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.977B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.140B | 26.63 |
| BellRing Brands (BRBR) | United States | $7.808B | 36.57 |
| Lantheus Holdings (LNTH) | United States | $5.398B | 13.45 |
| Haemonetics (HAE) | United States | $4.886B | 24.17 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.199B | 12.73 |
| Prestige Consumer Healthcare (PBH) | United States | $3.500B | 16.55 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $2.820B | 15.65 |
| Neogen (NEOG) | United States | $2.781B | 26.75 |
| Green Thumb Industries (GTBIF) | United States | $2.736B | 54.19 |
| TG Therapeutics (TGTX) | United States | $2.677B | 75.30 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.647B | 0.00 |
| ICU Medical (ICUI) | United States | $2.641B | 23.31 |
| Agios Pharmaceuticals (AGIO) | United States | $1.904B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.711B | 50.14 |
| Verano Holdings (VRNOF) | United States | $1.693B | 0.00 |
| InMode (INMD) | Israel | $1.553B | 8.25 |
| Warby Parker (WRBY) | United States | $1.536B | 0.00 |
| Owens & Minor (OMI) | United States | $1.431B | 12.47 |
| AdaptHealth (AHCO) | United States | $1.263B | 9.41 |
| National Vision Holdings (EYE) | United States | $1.174B | 37.35 |
| AtriCure (ATRC) | United States | $1.069B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.951B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.950B | 0.00 |
| Evolus (EOLS) | United States | $0.790B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.734B | 15.61 |
| Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
| Quanterix (QTRX) | United States | $0.645B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.634B | 14.91 |
| PetIQ (PETQ) | United States | $0.572B | 18.69 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| Jin Medical (ZJYL) | China | $0.515B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.498B | 0.00 |
| Surmodics (SRDX) | United States | $0.463B | 28.97 |
| ZimVie (ZIMV) | United States | $0.459B | 39.12 |
| Biote (BTMD) | United States | $0.448B | 8.59 |
| OraSure Technologies (OSUR) | United States | $0.382B | 12.29 |
| Aurora Cannabis (ACB) | Canada | $0.364B | 0.00 |
| Zynex (ZYXI) | United States | $0.339B | 46.44 |
| MacroGenics (MGNX) | United States | $0.274B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 27.11 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 15.22 |
| Omeros (OMER) | United States | $0.217B | 0.00 |
| Veru (VERU) | United States | $0.195B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.190B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.171B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.154B | 74.00 |
| InterCure (INCR) | Israel | $0.141B | 23.77 |
| FitLife Brands (FTLF) | United States | $0.140B | 22.57 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.110B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.83 |
| MariMed (MRMD) | United States | $0.099B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| Chimerix (CMRX) | United States | $0.094B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.093B | 0.00 |
| Brainsway (BWAY) | Israel | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.073B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.067B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.81 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Exagen (XGN) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |